Can a simple blood test predict liver cancer treatment success?

This study aims to find tiny genetic markers (microRNAs) and blood chemicals that can tell doctors early whether a liver cancer patient will fully respond to heat-based tumor destruction. Researchers will analyze blood and tumor tissue samples from 150 adults with early-stage liver cancer before and after treatment. The goal is to improve personalized treatment decisions, not to test a new therapy.